
|Articles|July 8, 2008
FDA approves Evolence for treating facial wrinkles
National report - The U.S. Food and Drug Administration has approved Evolence to treat moderate-to-severe facial wrinkles and folds, according to maker Johnson and Johnson.
Advertisement
National report
- The U.S. Food and Drug Administration has approved Evolence to treat moderate-to-severe facial wrinkles and folds, according to maker Johnson and Johnson.
Evolence is made from collagen harvested from the tendons of pigs, and will compete on the market with synthetic dermal fillers, such as Restylane (Medicis) and Juvéderm (Allergan), the Washington Post reports.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
CSU With Biochemical C1 Inhibitor Deficiency: Case Report Raises Diagnostic Questions
2
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
3
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
4
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
5











